|
HNRNPF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.793400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.853190E-01 |
| Normal-vs-Stage2 |
7.859800E-02 |
| Normal-vs-Stage3 |
5.307600E-01 |
| Normal-vs-Stage4 |
9.635200E-01 |
| Stage1-vs-Stage2 |
3.039800E-03 |
| Stage1-vs-Stage3 |
5.374400E-01 |
| Stage1-vs-Stage4 |
1.986980E-01 |
| Stage2-vs-Stage3 |
1.737630E-02 |
| Stage2-vs-Stage4 |
9.435600E-02 |
| Stage3-vs-Stage4 |
5.473600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.962400E-01 |
| Normal-vs-AfricanAmerican |
6.995600E-01 |
| Normal-vs-Asian |
2.970400E-01 |
| Caucasian-vs-AfricanAmerican |
8.169800E-01 |
| Caucasian-vs-Asian |
7.517200E-01 |
| AfricanAmerican-vs-Asian |
6.585800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.758400E-01 |
| Normal-vs-Female |
4.155600E-01 |
| Male-vs-Female |
5.987400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.210200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.065200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.094000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.242400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.520420E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.482350E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.524200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.959800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.574800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.881600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.878200E-01 |
| Classical-VS-Follicular |
1.12843068222901E-12 |
| Classical-VS-Other |
2.087400E-01 |
| Classical-VS-Normal |
2.080300E-02 |
| Tall-VS-Follicular |
1.37499999997015E-06 |
| Tall-VS-Other |
1.389440E-01 |
| Tall-VS-Normal |
2.839500E-02 |
| Follicular-VS-Other |
2.856800E-01 |
| Follicular-VS-Normal |
6.375200E-04 |
| Other-VS-Normal |
7.323400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.730400E-01 |
| Normal-vs-N1 |
6.226000E-01 |
| N0-vs-N1 |
2.172000E-01 |
|
|
